MLchartDataset catalogue

Bleomycin

Term · Oncology and biomedicine · MLC-T-ONC-012057

A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.

Table 1. Record
IdentifierMLC-T-ONC-012057
FieldOncology and biomedicine
AbbreviationBLEO
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012057",
  "term": "Bleomycin",
  "field": "Oncology and biomedicine",
  "definition": "A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.",
  "abbreviation": "BLEO",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bleomycin/"
}

Record 3,653 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.